<DOC>
	<DOCNO>NCT02515669</DOCNO>
	<brief_summary>The purpose study determine safety tolerability BMS-986089 boys Duchenne Muscular Dystrophy genetic mutation .</brief_summary>
	<brief_title>Study Investigational Drug , BMS-986089 , Ambulatory Boys With DMD</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Diagnosed DMD blood test Able walk without assistance Able walk 4 stair 8 second less Weigh least 15 kg Taking corticosteroid DMD Any behavior mental issue affect ability complete require study procedure Previously currently take medication like androgen human growth hormone Use ventilator day Unable blood sample collect receive injection skin</criteria>
	<gender>Male</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>